SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4/A

Amendment to a previously filed 4

3,4,5
View HTML
4/A

Amendment to a previously filed 4

3,4,5
View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

3,4,5
View HTML
S-3

Simplified registration form

Registration Statements
View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

3,4,5
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe